<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An induction of amyloid precursor protein (APP) <z:chebi fb="2" ids="33699">mRNA</z:chebi> was examined in a middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model of rats using Northern blot analyses </plain></SENT>
<SENT sid="1" pm="."><plain>The level of tubulin <z:chebi fb="2" ids="33699">mRNA</z:chebi> was measured as an internal standard </plain></SENT>
<SENT sid="2" pm="."><plain>With persistent focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, APP <z:chebi fb="2" ids="33699">mRNA</z:chebi> species which contain a Kunitz-type <z:chebi fb="0" ids="37670">protease inhibitor</z:chebi> (KPI) domain were induced in the rat cerebral cortex from 1 to 21 days after the insult with a maximum at 4 days, while total amounts of APP <z:chebi fb="2" ids="33699">mRNA</z:chebi> did not change </plain></SENT>
<SENT sid="3" pm="."><plain>No change was observed in the level of tubulin <z:chebi fb="2" ids="33699">mRNA</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>These results suggest a selective role of APP species which contain the KPI domain in focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>